Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors of Residual Tumor at Second Transurethral Resection for pT1 Non-muscle Invasive Bladder Cancer

NCT06205277 is registered in ClinicalTrials.gov with University of Trieste as lead sponsor.

NCT NCT06205277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06205277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors of Residual Tumor at Second Transurethral Resection for pT1 Non-muscle Invasive Bladder Cancer
Lead sponsor
University of Trieste
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
December 31, 2023
Enrollment
1,300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, non muscle invasive bladder cancer